GB9523469D0 - Organic compounds - Google Patents

Organic compounds

Info

Publication number
GB9523469D0
GB9523469D0 GBGB9523469.6A GB9523469A GB9523469D0 GB 9523469 D0 GB9523469 D0 GB 9523469D0 GB 9523469 A GB9523469 A GB 9523469A GB 9523469 D0 GB9523469 D0 GB 9523469D0
Authority
GB
United Kingdom
Prior art keywords
organic compounds
compounds
organic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
GBGB9523469.6A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sandoz AG
Original Assignee
Sandoz AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz AG filed Critical Sandoz AG
Priority to GBGB9523469.6A priority Critical patent/GB9523469D0/en
Publication of GB9523469D0 publication Critical patent/GB9523469D0/en
Priority to CO96060058A priority patent/CO4520295A1/en
Priority to CN96198369A priority patent/CN1202200A/en
Priority to EP96939066A priority patent/EP0879285A1/en
Priority to AU76848/96A priority patent/AU7684896A/en
Priority to ZA9609623A priority patent/ZA969623B/en
Priority to JP9518596A priority patent/JP2000500336A/en
Priority to PCT/EP1996/005039 priority patent/WO1997018307A1/en
Priority to BR9611734A priority patent/BR9611734A/en
Priority to CA002232876A priority patent/CA2232876A1/en
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70575—NGF/TNF-superfamily, e.g. CD70, CD95L, CD153, CD154
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence

Landscapes

  • Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Toxicology (AREA)
  • Cell Biology (AREA)
  • Transplantation (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
GBGB9523469.6A 1995-11-16 1995-11-16 Organic compounds Pending GB9523469D0 (en)

Priority Applications (10)

Application Number Priority Date Filing Date Title
GBGB9523469.6A GB9523469D0 (en) 1995-11-16 1995-11-16 Organic compounds
CO96060058A CO4520295A1 (en) 1995-11-16 1996-11-14 FUSION PROTEIN
CA002232876A CA2232876A1 (en) 1995-11-16 1996-11-15 Fas ligand fusion protein
AU76848/96A AU7684896A (en) 1995-11-16 1996-11-15 Fas ligand fusion protein
EP96939066A EP0879285A1 (en) 1995-11-16 1996-11-15 Fas ligand fusion protein
CN96198369A CN1202200A (en) 1995-11-16 1996-11-15 Fas ligang fusion protein
ZA9609623A ZA969623B (en) 1995-11-16 1996-11-15 Fas Ligand fusion protein.
JP9518596A JP2000500336A (en) 1995-11-16 1996-11-15 Fas ligand fusion protein
PCT/EP1996/005039 WO1997018307A1 (en) 1995-11-16 1996-11-15 Fas ligand fusion protein
BR9611734A BR9611734A (en) 1995-11-16 1996-11-15 Fas ligand fusion protein

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9523469.6A GB9523469D0 (en) 1995-11-16 1995-11-16 Organic compounds

Publications (1)

Publication Number Publication Date
GB9523469D0 true GB9523469D0 (en) 1996-01-17

Family

ID=10784000

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB9523469.6A Pending GB9523469D0 (en) 1995-11-16 1995-11-16 Organic compounds

Country Status (10)

Country Link
EP (1) EP0879285A1 (en)
JP (1) JP2000500336A (en)
CN (1) CN1202200A (en)
AU (1) AU7684896A (en)
BR (1) BR9611734A (en)
CA (1) CA2232876A1 (en)
CO (1) CO4520295A1 (en)
GB (1) GB9523469D0 (en)
WO (1) WO1997018307A1 (en)
ZA (1) ZA969623B (en)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6544523B1 (en) * 1996-11-13 2003-04-08 Chiron Corporation Mutant forms of Fas ligand and uses thereof
GB9705744D0 (en) * 1997-03-20 1997-05-07 Davies Alison M Methods for selecting cells and their uses
US6972323B1 (en) 1997-04-01 2005-12-06 Sankyo Company, Limited Anti-Fas antibodies
IL123888A0 (en) * 1997-04-01 1998-10-30 Sankyo Co Anti-fas antibodies
US6451759B1 (en) * 1998-01-14 2002-09-17 The Regents Of The University Of California Noncleavable Fas ligand
AU2880400A (en) * 1999-02-12 2000-08-29 Amgen, Inc. Tnf-related proteins
GB9905503D0 (en) 1999-03-10 1999-05-05 Adprotech Plc Novel compound formulations and methods of delivery
DE60127933T2 (en) * 2000-01-03 2008-02-07 Mark L. Merion Station Tykocinski CHIMERIC PROTEINS AND APPLICATIONS
CA2396979C (en) * 2000-01-24 2015-07-14 University Of Louisville Research Foundation, Inc. Immune modulation with death receptor-induced apoptosis
US7927602B2 (en) 2002-07-23 2011-04-19 University Of Louisville Research Foundation, Inc. Fas ligand-avidin/streptavidin fusion proteins
AU1676302A (en) 2000-06-30 2002-01-14 Univ Louisville Res Found Alteration of cell membrane for new functions
CN103153332A (en) 2010-09-28 2013-06-12 卡尔医疗有限公司 Compositions and methods for treatment of hematological malignancies
WO2018152451A1 (en) * 2017-02-17 2018-08-23 Purdue Research Foundation Targeted ligand-payload based drug delivery for cell therapy
AU2018230474B2 (en) * 2017-03-10 2023-08-03 Georgia Tech Research Corporation FasL-engineered biomaterials with immunomodulatory function

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6237145U (en) * 1985-08-23 1987-03-05
US5223408A (en) * 1991-07-11 1993-06-29 Genentech, Inc. Method for making variant secreted proteins with altered properties
JPH0590011A (en) * 1991-09-26 1993-04-09 Anritsu Corp Thermosensitive resistor and its manufacture
JPH05332845A (en) * 1992-06-03 1993-12-17 Kobe Steel Ltd Output conversion method and device of temperature detector
DE69535719T2 (en) * 1994-01-07 2009-03-19 Mochida Pharmaceutical Co. Ltd. FAS-ANTIGEN-BINDING LIGAND

Also Published As

Publication number Publication date
CA2232876A1 (en) 1997-05-22
EP0879285A1 (en) 1998-11-25
CN1202200A (en) 1998-12-16
ZA969623B (en) 1998-05-15
AU7684896A (en) 1997-06-05
CO4520295A1 (en) 1997-10-15
WO1997018307A1 (en) 1997-05-22
JP2000500336A (en) 2000-01-18
BR9611734A (en) 1999-02-23

Similar Documents

Publication Publication Date Title
GB9523469D0 (en) Organic compounds
GB9509156D0 (en) Organic compounds
GB9510477D0 (en) Organic compounds
GB9521322D0 (en) Organic compounds
GB9511486D0 (en) Organic compounds
GB9509159D0 (en) Organic compounds
GB9509186D0 (en) Organic compounds
GB9503092D0 (en) Organic compounds
GB9511704D0 (en) Organic compounds
GB9512958D0 (en) Organic compounds
GB9511048D0 (en) Organic compounds
GB9511046D0 (en) Organic compounds
GB9510675D0 (en) Organic compounds
GB9510674D0 (en) Organic compounds
GB9510613D0 (en) Organic compounds
GB9510478D0 (en) Organic compounds
GB9507134D0 (en) Organic compounds
GB9510209D0 (en) Organic compounds
GB9509516D0 (en) Organic compounds
GB9509400D0 (en) Organic compounds
GB9509399D0 (en) Organic compounds
GB9509397D0 (en) Organic compounds
GB9509394D0 (en) Organic compounds
GB9507674D0 (en) Organic compounds
GB9507479D0 (en) Organic compounds